Mounjaro – medicarereport.org

A trusted source for Medicare news and education from the AMAC Foundation.

FDA adds warning to Ozempic, Mounjaro and other GLP-1 labels

(By Alexandra Murphy for Becker’s Hospital Review ) The FDA has updated the labels for all GLP-1 receptor agonists, including

Eileen Cook November 7, 2024November 7, 2024 FDA, GLP-1 drugs, Mounjaro, Ozempic

CMS Emerging Health Issues Health Care - General Health Insurance Medicare - General Part D/Prescription Drugs

Poll: 1 in 8 Adults Say They’ve Taken a GLP-1 Drug, Including 4 in 10 of Those with Diabetes and 1 in 4 of Those with Heart Disease

(By Tammie Smith at The Kaiser Family Foundation published May 10, 2024) About one in eight adults (12%) say they

Eileen Cook May 10, 2024May 10, 2024 CMS, Diabetes, Emerging Healthcare, GLP-1s drugs, Healthcare Costs, heart disease, medicare, Medicare Part D, Mounjaro, Obesity, Ozempic, Wegovy